The Acr‐Aca Fusion Protein AcrIF16 Dually Inhibits the Type I‐F CRISPR‐Cas System Through DNA Sequestration
The FASEB Journal · 30.11.2026 · 40 (22)
DOI: 10.1096/fj.202602129r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 20.11.2026. Verfasst von Lingguang Yang und 6 weiteren Autor:innen. Die Arbeit nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Anti‐CRISPR (Acr) proteins are natural inhibitors of CRISPR‐Cas systems, offering valuable tools for regulating genome editing. Most characterized Acrs function through direct protein–protein interactions with Cas effectors. Here, we report that AcrIF16, an Acr‐Aca fusion protein from Pectobacterium parmentieri , inhibits the type I‐F CRISPR‐Cas system through a DNA‐binding‐dependent dual mechanism without forming stable complexes with the Csy surveillance complex or the Cas2/3 nuclease. The high‐resolution crystal structure of its N‐terminal domain (NTD) reveals a canonical helix‐turn‐helix (HTH) motif that specifically binds inverted repeat sequences upstream of the acrIF16 locus. Structural prediction of the C‐terminal domain (CTD) suggests a previously uncharacterized fold, although its functional role remains to be determined. Biochemical assays demonstrate that AcrIF16 binds double‐stranded DNA in a sequence‐non‐specific manner, thereby competing with Csy for target DNA binding and destabilizing pre‐assembled Csy–DNA complexes. Furthermore, AcrIF16 inhibits Cas2/3‐mediated single‐stranded and double‐stranded DNA cleavage, an effect attributable to substrate sequestration rather than direct Cas2/3 binding. In vivo, AcrIF16 restores phage plaque formation in E. coli cells expressing the type I‐F CRISPR‐Cas system, supporting its anti‐CRISPR activity. Thus, AcrIF16 employs a DNA‐sequestration strategy to block both target recognition and DNA degradation in the type I‐F CRISPR‐Cas system. This work expands the mechanistic repertoire of anti‐CRISPR proteins and highlights DNA‐binding Acrs as a distinct class of CRISPR inhibitors.
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
Zitieren
APA
Yang, L., Liu, X., Hou, J., Liu, H., Yin, P., Wang, H., & Zhang, Y. (2026). The Acr‐Aca Fusion Protein AcrIF16 Dually Inhibits the Type I‐F CRISPR‐Cas System Through DNA Sequestration. The FASEB Journal, 40(22). https://doi.org/10.1096/fj.202602129r
Vancouver
Yang L, Liu X, Hou J, Liu H, Yin P, Wang H, et al. The Acr‐Aca Fusion Protein AcrIF16 Dually Inhibits the Type I‐F CRISPR‐Cas System Through DNA Sequestration. The FASEB Journal. 2026;40(22). doi:10.1096/fj.202602129r
BibTeX
@article{Yang2026,
author = {Yang, Lingguang and Liu, Xi and Hou, Jiaxin and Liu, Hui and Yin, Peipei and Wang, Hao and Zhang, Yi},
title = {The Acr‐Aca Fusion Protein AcrIF16 Dually Inhibits the Type I‐F CRISPR‐Cas System Through DNA Sequestration},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {22},
doi = {10.1096/fj.202602129r}
}
EUVIMED